In spite of substantial improvement in outcomes in the past 2 decades, we continue to face significant challenges in treating patients with HF. There have been several epidemiologic, pathophysiologic, and randomized controlled trials evaluating different treatment modalities published in the past year. In this review, we summarize the most relevant studies that we believe could significantly impact the understanding and management of HF.
© 2011 Wiley Periodicals, Inc.